Trevena
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Trevena and buy or sell other stocks, ETFs, and their options commission-free!About TRVN
Trevena, Inc. engages in the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its product candidates include Oliceridine injection, TRV250, TRV734, and TRV045.
CEOCarrie L. Bourdow
CEOCarrie L. Bourdow
Employees43
Employees43
HeadquartersChesterbrook, Pennsylvania
HeadquartersChesterbrook, Pennsylvania
Founded2007
Founded2007
Employees43
Employees43
TRVN Key Statistics
Market cap101.00M
Market cap101.00M
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume881.54K
Average volume881.54K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$0.97
52 Week high$0.97
52 Week low$0.1195
52 Week low$0.1195
Stock Snapshot
Trevena(TRVN) stock is priced at $0.58, giving the company a market capitalization of 101M.
During the trading day, Trevena(TRVN) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading activity shows a volume of 0, compared to an average daily volume of 881.54K.
The stock's 52-week range extends from a low of $0.12 to a high of $0.97.
The stock's 52-week range extends from a low of $0.12 to a high of $0.97.
People also own
Based on the portfolios of people who own TRVN. This list is generated using Robinhood data, and it’s not a recommendation.
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.